Analysis of Listed Recombinant Protein or Peptide Products for Therapeutic Use in China

Xin Zhongshuai, Zhang Yanyan, Jin Xiaoyan, Yang Jianhong

Chinese Pharmaceutical Affairs ›› 2019, Vol. 33 ›› Issue (9) : 991-997.

Chinese Pharmaceutical Affairs ›› 2019, Vol. 33 ›› Issue (9) : 991-997. DOI: 10.16153/j.1002-7777.2019.09.005

Analysis of Listed Recombinant Protein or Peptide Products for Therapeutic Use in China

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2019, 33(9): 991-997 https://doi.org/10.16153/j.1002-7777.2019.09.005

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉